HLB TherapeuticsLtd Dividends and Buybacks
Dividend criteria checks 0/6
HLB TherapeuticsLtd does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-1.2%
Buyback Yield
| Total Shareholder Yield | -1.2% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 36% Share Price Surge Not Quite Adding Up
Jan 03
HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Shares Climb 36% But Its Business Is Yet to Catch Up
Nov 18What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 36% Share Price Gain Is Not Telling You
Nov 18Is HLB TherapeuticsLtd (KOSDAQ:115450) A Risky Investment?
Sep 25What HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 27% Share Price Gain Is Not Telling You
Jul 22HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Popularity With Investors Under Threat As Stock Sinks 26%
Jun 03HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) 38% Share Price Surge Not Quite Adding Up
Apr 11There's Reason For Concern Over HLB Therapeutics Co.,Ltd.'s (KOSDAQ:115450) Massive 50% Price Jump
Feb 26Does G-treeBNT (KOSDAQ:115450) Have A Healthy Balance Sheet?
Mar 19Did Business Growth Power G-treeBNT's (KOSDAQ:115450) Share Price Gain of 134%?
Dec 21
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A115450's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A115450's dividend payments have been increasing.
Dividend Yield vs Market
| HLB TherapeuticsLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A115450) | n/a |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Biotechs) | 0.6% |
| Analyst forecast (A115450) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A115450's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A115450's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A115450's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A115450 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 03:19 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HLB Therapeutics Co.,Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jae Kim | DAOL Investment & Securities Co., Ltd. |
| Seung Kyu Jung | Kiwoom Securities Co., Ltd. |